Sanchez e Oliveira Rita de Cássia, Valente Paulo Roberto, Abou-Jamra Rogério C, Araújo Andrezza, Saldiva Paulo Hilário, Pedreira Denise Araújo Lapa
Pathology Department, FMUSP, São Paulo, Brazil.
Acta Cir Bras. 2007 May-Jun;22(3):174-81. doi: 10.1590/s0102-86502007000300004.
The aim of this study was to compare the effectiveness of two dura-mater substitutes, namely human acellular dermal matrix (HADM) and biosynthetic cellulose (BC), in repairing, in utero, surgically-induced meningomyelocele (MMC) in fetal sheep.
A neural tube defect was created at 74-77 days gestation in 36 fetal sheep. They were divided into 3 groups, the control group that did not receive pre-natal corrective surgery, and the other two groups that received corrective surgery using HADM (Group A) or BC (Group B). Both materials were used as a dura-mater substitutes between the neural tissue and the sutured skin. Correction was performed at gestation day 100 and the fetuses were maintained in utero until term. Sheep were sacrificed on gestation day 140. The fetal spine was submitted to macro and microscopic analysis. At microscopy, adherence of the material to the skin and neural tissue was analyzed.
In the initial phase (pilot), experimentally-induced MMC was performed on 11 fetuses and 4 survived (37%). In the second phase (study), 25 fetuses received surgery and 17 survived (68%). In the study group, 6 fetuses did not undergo repair (control group), 11 cases were submitted to corrective surgery (experimental group) and one fetal loss occurred. Of the surviving cases in the experimental group, 4 constituted Group A and 6 in Group B. Macroscopically, skin and underlying tissues where easily displaced from the BC in all cases it was used; in contrast, HADM adhered to these tissues. To compare the adherence, 4 cases from Group A and 4 in Group B were studied. We observed adherence, host cell migration and vessel proliferation into the HADM all sections from Group A and this aspect was not present in any cases in Group B (p < 0.05). In Group B, we also observed that a new fibroblast layer formed around the BC thus protecting the medulla and constituting a "neoduramater".
The use of BC seems to be more adequate as a dura-mater substitute to cover the damaged neural tissue than HADM. It seems promising for use in the in utero correction of MMC because to does not adhere to neural tissue of superficial and deep layers ("tethered spinal cord"). Thus, BC minimizes the mechanical and chemical intrauterine damage to the spinal medulla.
本研究旨在比较两种硬脑膜替代物,即人脱细胞真皮基质(HADM)和生物合成纤维素(BC),在子宫内修复胎羊手术诱导的脊髓脊膜膨出(MMC)的有效性。
在36只胎羊妊娠74 - 77天时制造神经管缺陷。它们被分为3组,未接受产前矫正手术的对照组,以及另外两组分别使用HADM(A组)或BC(B组)进行矫正手术的组。两种材料均用作神经组织与缝合皮肤之间的硬脑膜替代物。在妊娠第100天进行矫正,胎儿在子宫内维持至足月。在妊娠第140天处死绵羊。对胎儿脊柱进行大体和显微镜分析。在显微镜下,分析材料与皮肤和神经组织的粘附情况。
在初始阶段(试点),对11只胎儿进行了实验性诱导的MMC,4只存活(37%)。在第二阶段(研究),25只胎儿接受了手术,17只存活(68%)。在研究组中,6只胎儿未进行修复(对照组),11例接受了矫正手术(实验组),发生1例胎儿死亡。在实验组存活的病例中,4例为A组,6例为B组。大体上,在所有使用BC的病例中,皮肤和下层组织很容易从BC上移位;相反,HADM与这些组织粘附。为比较粘附情况,研究了A组的4例和B组的4例。我们观察到A组所有切片中HADM均有粘附、宿主细胞迁移和血管增生,而B组任何病例均未出现此情况(p < 0.05)。在B组中,我们还观察到BC周围形成了一层新的成纤维细胞层,从而保护了延髓并构成了“新硬脑膜”。
作为覆盖受损神经组织的硬脑膜替代物,BC的使用似乎比HADM更合适。它在子宫内矫正MMC方面似乎很有前景,因为它不粘附于浅层和深层神经组织(“脊髓栓系”)。因此,BC将子宫内对脊髓的机械和化学损伤降至最低。